These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29986891)

  • 1.
    Chandler CE; Harberts EM; Laemmermann T; Zeng Q; Opene BN; Germain RN; Jewell CM; Scott AJ; Ernst RK
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia.
    Pammit MA; Raulie EK; Lauriano CM; Klose KE; Arulanandam BP
    Infect Immun; 2006 Apr; 74(4):2063-71. PubMed ID: 16552035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BALB/c mice, but not C57BL/6 mice immunized with a ΔclpB mutant of Francisella tularensis subspecies tularensis are protected against respiratory challenge with wild-type bacteria: association of protection with post-vaccination and post-challenge immune responses.
    Twine S; Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    Vaccine; 2012 May; 30(24):3634-45. PubMed ID: 22484348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic intradermal delivery of tumor necrosis factor-alpha antibodies using tip-loaded dissolvable microneedle arrays.
    Korkmaz E; Friedrich EE; Ramadan MH; Erdos G; Mathers AR; Burak Ozdoganlar O; Washburn NR; Falo LD
    Acta Biomater; 2015 Sep; 24():96-105. PubMed ID: 26093066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cells are required during priming but not the effector phase of antibody-mediated IFN-gamma-dependent protective immunity against pulmonary Francisella novicida infection.
    Powell HJ; Cong Y; Yu JJ; Guentzel MN; Berton MT; Klose KE; Murthy AK; Arulanandam BP
    Immunol Cell Biol; 2008; 86(6):515-22. PubMed ID: 18427567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of protection against Francisella novicida in mice depends on the pathogenicity protein PdpA, but not PdpC or PdpD.
    Chou AY; Kennett NJ; Nix EB; Schmerk CL; Nano FE; Elkins KL
    Microbes Infect; 2013 Nov; 15(12):816-27. PubMed ID: 23880085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge.
    Tempel R; Lai XH; Crosa L; Kozlowicz B; Heffron F
    Infect Immun; 2006 Sep; 74(9):5095-105. PubMed ID: 16926401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice.
    Quarry JE; Isherwood KE; Michell SL; Diaper H; Titball RW; Oyston PC
    Vaccine; 2007 Mar; 25(11):2011-8. PubMed ID: 17241711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination.
    Chen F; Yan Q; Yu Y; Wu MX
    J Control Release; 2017 Jun; 255():36-44. PubMed ID: 28390901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine survival of infection with Francisella novicida and protection against secondary challenge is critically dependent on B lymphocytes.
    Chou AY; Kennett NJ; Melillo AA; Elkins KL
    Microbes Infect; 2017 Feb; 19(2):91-100. PubMed ID: 27965147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
    Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
    Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F. novicida-Infected A. castellanii Does Not Enhance Bacterial Virulence in Mice.
    Ozanic M; Gobin I; Brezovec M; Marecic V; Trobonjaca Z; Abu Kwaik Y; Santic M
    Front Cell Infect Microbiol; 2016; 6():56. PubMed ID: 27242974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coated microneedle arrays for transcutaneous delivery of live virus vaccines.
    Vrdoljak A; McGrath MG; Carey JB; Draper SJ; Hill AV; O'Mahony C; Crean AM; Moore AC
    J Control Release; 2012 Apr; 159(1):34-42. PubMed ID: 22245683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.